MEDIFAST INC
For the period ended Mar 31, 2024. Filed Apr 29, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed Apr 29, 2024
MED$13.37+4.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. – Financial Statements
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)
(U.S. dollars in thousands, except per share amounts & dividend data)
| Three months ended March 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Revenue | $174,739 | $348,983 |
| Cost of sales | 47,447 | 102,593 |
| Gross profit | 127,292 | 246,390 |
| Selling, general, and administrative | 119,352 | 192,879 |
| Income from operations | 7,940 | 53,511 |
| Other income (expense) | ||
| Interest income (expense) | 1,223 | (181) |
| Other income (expense) | 2,422 | (1) |
| 3,645 | (182) | |
| Income from operations before income taxes | 11,585 | 53,329 |
| Provision for income taxes | 3,269 | 13,361 |
| Net income | $8,316 | $39,968 |
| Earnings per share - basic | $0.76 | $3.68 |
| Earnings per share - diluted | $0.76 | $3.67 |
| Weighted average shares outstanding | ||
| Basic | 10,909 | 10,864 |
| Diluted | 10,958 | 10,899 |
| Cash dividends declared per share | $— | $1.65 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.